|
MechanismNS5B polymerase inhibitors [+2] |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of Orally Administered GS-441524 in a Healthy Human Volunteer
This is a two-part study is to evaluate the multi-day safety, tolerability, and pharmacokinetics (PK) of orally administered GS-441524 in a healthy human volunteer.
100 Clinical Results associated with Copycat Sciences LLC
0 Patents (Medical) associated with Copycat Sciences LLC
100 Deals associated with Copycat Sciences LLC
100 Translational Medicine associated with Copycat Sciences LLC